SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Google

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
Lockdown leads to double unplanned pregnancies
Fri October 22nd - Unplanned pregnancies almost doubled during the first lockdown in the UK, a major study reports today. More
Promising development in treatment for glioblastoma multiforme
Fri October 22nd - A major advance in brain tumour research could pave the way for personalised treatment for the most deadly form of the disease, British scientists say. More
RECENT COMMENTS
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
OUR CLIENTS
THIS WEEK'S STORIES
Flu & Viruses

Flu & Viruses

picture of influenza A virus

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50

18/12/2020 - Prepare patients for "long COVID," doctors told
Doctors should prepare COVID-19 patients for long-term effects, according to guidance published today. More

17/12/2020 - Concerns over COVID-19 vaccine coverage
Low and middle income countries will face huge problems in obtaining supplies of COVID-19 vaccines because of pre-ordering by wealthy countries, according to a new analysis. More

17/12/2020 - COVID trials have excluded pregnant women - study
Most COVID-19 trials have avoided including pregnant women, according to a new analysis. More

15/12/2020 - New strain appears in southern third wave
A new strain of SARS-CoV-2 has been linked to the resurgence of the pandemic in southern England, it has been announced. More

14/12/2020 - Genes point to severe COVID illness
Scottish researchers have identified five genes linked to patients developing the most severe forms of COVID-19, it has been announced. More

10/12/2020 - Loss of taste and smell among hospitalised COVID patients
Almost two-thirds of people admitted to an Italian hospital with COVID-19 at the beginning of the pandemic had lost their senses of smell and taste, according to a small study published yesterday. More

09/12/2020 - Much ado as vaccination begins
The Oxford university COVID-19 vaccine still lacks data on its effectiveness on adults over the age of 55, according to the first peer-reviewed analysis of the new vaccines. More

04/12/2020 - Pandemic mortality risk for people with rare autoimmune disease
People with rare autoimmune rheumatic diseases have been at greater risk of dying during the COVID-19 pandemic than the general population, according to a study published today. More

03/12/2020 - 'Lab-on-a-chip' infection test developed
A newly developed chip that is a miniature version of the polymerase chain reaction can process results in minutes, British scientists have announced. More

02/12/2020 - Hand sanitiser poisoning reported
The widespread use of alcohol-based hand sanitiser is creating risk of accidental poisoning, a researcher warns today. More

27/11/2020 - Warning of spread of undiagnosed HIV in Europe
Parts of Europe are losing control of the spread of HIV, leading to thousands of people living with undiagnosed disease, according to a major new report. More

26/11/2020 - SARS-CoV-2 mutations 'do not increase transmissibility'
None of the SARS-CoV-2 virus mutations that have been documented so far increase transmissibility in humans, a new study has shown. More

25/11/2020 - Severe COVID-19 risk with diabetic retinopathy
People with diabetic retinopathy are at a raised risk if they become infected with COVID-19, a study has found. More

23/11/2020 - COVID does not recur for six months - Oxford study
People infected with COVID-19 are unlikely to succumb to the virus again for at least six months, according to a new study. More

20/11/2020 - Hypertension link to social isolation during lockdown
Social isolation due to COVID-19 lockdowns is associated with an increase in blood pressure, according to a new Argentine study. More

20/11/2020 - 'Anti COVID-19' nasal spray developed
A nasal spray has been developed that could protect against COVID-19, using materials that are already cleared for use in humans, British researchers have announced. More

19/11/2020 - US vaccine approval draws near
Developers of the first COVID-19 vaccine will be seeking formal approval for use in the USA "within days", it has been announced. More

16/11/2020 - Baricitinib could reduce COVID-19 mortality
Baricitinib, the rheumatoid arthritis drug, has shown promise as a treatment that could help to reduce COVID-19 mortality, an early-stage study has found. More

13/11/2020 - Inhaled treatment could help severe COVID disease
An inhaled immune system protein, developed for asthma, can help patients with severe COVID-19 disease, British researchers have reported. More

12/11/2020 - Doubts over fast antibody testing
A rapid antibody test will have limited use for telling the public whether they are safe against COVID-19 infection, researchers warn today. More

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50

Printer friendly page Printer friendly page

CATEGORIES